human secreted phospholipase A2 type IIA-integrin binding inhibiting peptides (University of California, Davis)

N/A

Report date: 2025/01/26 15:33:19

Base Information

Drug Namehuman secreted phospholipase A2 type IIA-integrin binding inhibiting peptides (University of California, Davis)
Drug Alias NamesPLA2-IIA-integrin binding inhibiting peptides (University of California, Davis)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsAlzheimer DiseaseAsthmaArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaThe University Of California Davis
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseAsthmaArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A